Lido Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Lido Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,739	Closed	-$423K	–	1273
2022 Q4	$423K	Buy	12,739 +916	+8%	+$29.5K	0.01%	660
2022 Q3	$372K	Buy	+11,823	New	+$383K	﹤0.01%	652

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lido Advisors's VIVO Position: Q1 2023 in Review

Lido Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 12,739 shares — an estimated $423K sold.

Lido Advisors first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $423K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Lido Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Lido Advisors sold 12,739 Meridian Bioscience Inc shares in Q1 2023, an estimated $423K.
Lido Advisors first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
Lido Advisors's Meridian Bioscience Inc position peaked at $423K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Lido Advisors's 13F filing for Q1 2023, filed 15 May 2023.